Status:
UNKNOWN
Inflammation and Cellular Immunity in Vaginal Tissue in Patients With Pelvic Organ Prolapse
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Pelvic Organ Prolapse
Eligibility:
FEMALE
18-80 years
Brief Summary
The aim of this study is to investigate the inflammatory and maturation processes of immature myeloid cells (IMC) in the vaginal tissue in women with advanced pelvic organ prolapse (POP) (stage III-IV...
Eligibility Criteria
Inclusion
- Women with POP undergoing colporrhaphy
- Women undergoing hysterectomy
Exclusion
- Autoimmune and connective tissue disorders
- Cancer in genital tract
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03748693
Start Date
December 1 2018
End Date
September 1 2019
Last Update
November 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.